We are digital architects of genomic medicine led by a team of technical and business experts dedicated to improving the progress and efficacy of healthcare in the genomic age. Our interdisciplinary team of designers, scientists and software engineers are merging the tools and techniques of genomics, data analytics, semantic reasoning and cloud computing to drive the next generation of scientific discovery and clinical care.
John received his PhD in theoretical physics from UCLA in 1990. Following a physics postdoc, he was awarded a 1992 NIH Special Emphasis Research Career Award to work on the Human Genome Project. After two years at the Salk Institute and two years at Stanford University, he moved to The Institute for Genomic Research, pioneering gene expression analysis. He joined the Dana-Farber Cancer Institute and Harvard School of Public Health in 2005 and works on reconstruction of gene networks that drive the development of disease. In 2012, he and Mick Correll launched Genospace to enable effective use of clinical and genomic data in precision medicine and for health and biomedical research. He received a 2013 White House Open Science Champion of Change award for his work on facilitating genomic data access.
Mick’s 15+ year career has tracked the path of genomics from basic research to clinical care. He has held a variety of positions leading the development of enterprise software solutions for pharmaceutical, biotech, and ag-bio organizations, as well as academic, government, and community healthcare providers. Prior to launching Genospace, he and partner John Quackenbush established the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute. Mick began his career at Lion Bioscience Research Inc. and UK-based informatics provider InforSense.
Mick earned a BS in computer science and a BA in molecular biology from the University of Colorado at Boulder.
Chief Technology Officer
Niall is responsible for software development, engineering and security at Genospace. Prior to Genospace, he was a Lead Engineer at the Center for Cancer Computational Biology (CCCB) at the Dana-Farber Cancer Institute. Prior to his work at the DFCI, he was a Security Software Engineer at Fidelity Investments, where he led the development of customer identity protection systems for Fidelity.com.
Niall holds a BE in electronics and computers from the National University of Ireland, Galway. He organizes charity events such as A Bout to Benefit and is a member of the MIT rugby club.
Jessica leads the Genospace scientific and clinical interpretation teams, which are responsible for curating Genospace content on clinically actionable molecular alterations and for providing scientific insight into product development. Before joining Genospace, Jessica was a scientific editor at N-of-One, Inc., where her work focused on writing and editing clinical interpretation reports for molecular tests in oncology. Previously, Jessica was a research associate in the Laboratory for Personalized Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center (BIDMC) and as a postdoctoral fellow in a cancer biology lab at Harvard Medical School and BIDMC.
Jessica holds a BS in chemistry from Providence College and a PhD in chemistry from Brown University.